PAPGENE, INC.

BALTIMORE, MD · Founded 2014 · CIK 0001634570 · Medtech · Acquired

PapGene: a genetic sequencing-based cytology test that detects ovarian and endometrial cancer from Pap specimens by identifying cancer-causing DNA mutations

Grants
$4.1M
3 awards
Sector median: 1
Raised
$3.0M
1 Form D · Feb 2015
140 months since last filing
Contracts
$1.5M
1 award · Health and Human S
#264 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,000,089
Federal grantDepartment of Health and Human Services · Phase I · Genetic Cytology for Ovarian and Endometrial Cancer Screening$1,286,663
Federal contractDepartment of Health and Human Services · Igf::ot::igf Genetic Cytology For Surveillance Of Recurrent Bladder Cancer$1,490,821
Federal grantDepartment of Health and Human Services · Phase II · Genetic Cytology for Ovarian and Endometrial Cancer Screening$910,751
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
261CIENCIA INC$1.5M—
262FOOTHOLD LABS INC$1.5M$4K
263YOUV LABS$1.5M—
264PAPGENE, INC.$1.5M$3.0M
265NEOCIS INC$1.5M$119M
266JSL Innovations LLC$1.5M—
267APPLIED BIOPHYSICS, INC.$1.4M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • HOWARD KAUFMANExecutive Officer
  • ISAAC KINDEExecutive Officer
  • KENNETH KINZLERDirector · Executive Officer
  • NICK PAPADOPOULOSDirector · Executive Officer
  • SHIBIN ZHOUDirector · Executive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.